How Long Will It Take to Reach Your Goal Weight?
Enter your current and goal weight to see a month-by-month projection based on the STEP (semaglutide) and SURMOUNT (tirzepatide) clinical trials.
~15%
Average body weight lost on semaglutide over 68 weeks
STEP 1 trial, NEJM 2021
~21%
Average body weight lost on tirzepatide over 72 weeks
SURMOUNT-1 trial, NEJM 2022
Shows both medications side by side based on clinical trial data.
Weight Loss Timeline, Common Questions
How long does it take to lose weight on semaglutide?
Most patients begin noticing appetite suppression within the first 2-4 weeks and measurable weight loss by weeks 6-8. The STEP 1 clinical trial showed an average of ~15% body weight loss over 68 weeks at the 2.4 mg maintenance dose. In real-world Houston programs, most patients lose 2-5% of body weight in the first month, 8-12% by month 3, and plateau around months 9-12 before stabilizing. Results vary based on dose, starting weight, adherence, diet, and exercise.
How long does it take to lose weight on tirzepatide?
Tirzepatide has faster and larger weight loss kinetics than semaglutide. SURMOUNT-1 data showed approximately 10-12% body weight loss at 12 weeks and a mean of 20-22% at 72 weeks on the highest dose (15 mg). Most Houston patients on tirzepatide notice significant appetite suppression by the 7.5 mg dose (weeks 9-10 of a standard escalation schedule). Tirzepatide generally produces visible results faster than semaglutide, though GI side effects during escalation can be more pronounced.
What is the dose escalation schedule for semaglutide and tirzepatide?
For semaglutide (Wegovy), the standard escalation is: 0.25 mg/week for 4 weeks → 0.5 mg for 4 weeks → 1.0 mg for 4 weeks → 1.7 mg for 4 weeks → 2.4 mg maintenance. Total time to maintenance dose: approximately 16-20 weeks. For tirzepatide (Zepbound), the standard escalation is: 2.5 mg/week for 4 weeks → 5 mg for 4 weeks → then optional increases to 7.5, 10, 12.5, or 15 mg every 4 weeks based on tolerability. Houston clinic protocols vary slightly, your provider will give you a specific schedule.
Why does weight loss slow down after a few months on GLP-1 medications?
Most patients experience a plateau around months 9-12 on semaglutide or tirzepatide. This is a predictable physiological response: as body weight decreases, the body's total daily energy expenditure also decreases, meaning the caloric deficit created by the medication becomes smaller. The body also adapts metabolically to the lower calorie intake. This is normal and not a sign the medication has stopped working. Houston providers typically address plateaus by evaluating protein intake, adding or intensifying resistance training, reviewing dose, and in some cases switching medications.
How does individual variation affect weight loss timelines on GLP-1 medications?
Clinical trials show the average, but the range around that average is wide. In STEP 1, roughly 1 in 3 participants lost 20% or more of body weight on semaglutide, while some patients lost less than 5%. Factors that affect timeline: starting weight (heavier patients often lose more total pounds but similar percentages), adherence to the dose schedule, dietary quality (particularly protein intake), resistance training, presence of insulin resistance or thyroid dysfunction, and genetics. If your results are significantly below average after 12 weeks at a therapeutic dose, discuss this with your Houston provider, there may be adjustable factors.
Find a Houston Physician to Start Your Plan
Browse verified, physician-supervised weight loss clinics across Greater Houston offering semaglutide and tirzepatide programs.
Browse Clinics Near You →